Characterization Of Anticancer And Antiviral Properties Of Natural Products In Kazakhstan | 10337
Journal of Ecosystem & Ecography
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The flora of Kazakhstan represents the rich biodiversity of Middle Asia. This region is continuously exposed to extreme
continental temperatures, but the composition and biological properties of plants in this region are largely unexplored.
Scientific collaboration of Kazakhstani scientists with leading research centers of the United States significantly expanded our
knowledge about the diversity of flora in different regions of Kazakhstan. Kazakhstan has approximately 6,000 species of plants,
677 of which are endemic. The chemical composition of 15% of plants has been studied to some degree, but the remaining has not
been explored for their chemical or pharmacological properties. During the last six years of collaborative work with the scientists
at the National Cancer Institute, USA, 220 species of plants and 58 plant extracts have been analyzed. Using knowledge-intensive
methods for analysis, we discovered that these plants and their extracts posses significant diversity, with 8.5% of them having
detectable pharmacological activity. Additional studies continue to reveal secondary metabolites with anti-tumor and/or antiviral
activity. In addition, seven individual compounds which have been derived from these natural products, have been isolated
and characterized. These are also being screened for anti-tumor and antiviral activity. Thus, the high biodiversity of the flora of
Kazakhstan has a great potential in the search for pharmacologically valuable substances. Preservation of these natural resources
is critical for maintenance of biodiversity in Middle Asia.
Khannanov Rinat, graduated from Moscow State University after M. Lomonosov in 2012 with a degree in biochemistry. His interests include but are
not limited by molecular biology, biotechnology and organic chemistry. At present time he is a junior scientist at the Branch of the National Center
for Biotechnology of the Republic of Kazakhstan and a project manager of the ISTC project K-1282 ?Microbiological synthesis of new medicine
preparation with tonic, anti-oxidant and anti-tumor activity?. ISTC project K-1282 is a joint project with the US National Institute of Health (National
Institute of Cancer), Bethesda, MD, USA
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals